Tamtam Try Tamtam free
WHOOP logo

WHOOP account plan

Unlocking human performance through technology

At a glance

WHOOP is a Boston screenless health wearable sold as a membership: over 2.5 million members, a $1.1B bookings run rate and a $10.1 billion valuation.

WHOOP, founded in 2012 by Will Ahmed with John Capodilupo and Aurelian Nicolae and headquartered in Boston, sells a screenless 24/7 wearable as a subscription membership. The band measures strain, recovery and sleep continuously, and the platform now adds an FDA-cleared ECG, Blood Pressure Insights, a Healthspan feature and Advanced Labs blood testing; members range from elite athletes to executives and military operators. It has over 2.5 million members, exited 2025 with bookings growing 103% year-over-year to a $1.1B run rate, and operated cash flow positive in 2025; it ships to 56 countries. WHOOP is private and independent, backed by venture and sovereign investors: its Series G of $575 million at a $10.1 billion valuation closed on 31 March 2026, led by Collaborative Fund, and the CEO calls an IPO the next step.

Strategic priorities

From fitness wearable to personal health platform
WHOOP says it is building "the personal health platform that people use to improve their health and livelihood", adding clinical features: WHOOP MG with an FDA-cleared ECG and blood pressure insights (May 2025), Advanced Labs blood testing (September 2025) and a women's health panel of 11 biomarkers (March 2026).
International expansion
Series G proceeds fund further U.S. growth and expansion across Europe, the GCC, Latin America and Asia, plus a faster global rollout of Advanced Labs.
AI coaching on continuous data
The company pairs more than 24 billion hours of physiological data with purpose-built AI models; the CEO expects wearable data, blood tests and other data sets to sit "under one roof" with an AI on top within two to three years.
Preparing for an IPO
The CEO expects the Series G to be the last private round and says the company is "doing a lot of the no-regrets work to be a public company"; in November 2025 he put a listing "over a horizon of two years."
Scaling the team
More than 600 new roles opened throughout 2026 across Software, Research & Design, Hardware, Product and Marketing, mostly at the Boston headquarters, with hiring in North America, Europe, the GCC and Asia.

Latest results

WHOOP does not publish accounts. In its March 2026 funding announcement it reported over 2.5 million members, 2025 bookings growth of 103% year-over-year to exit the year at a $1.1B run rate, and positive operating cash flow in 2025. Women represented 150% year-on-year growth in new members as of early 2026. The Series G raised $575 million at a $10.1 billion valuation, nearly tripling the $3.6 billion valuation of 2021.

Investments and deals

Series G funding
$575 million at a $10.1 billion valuation, closed 31 March 2026, led by Collaborative Fund with QIA, Mubadala, Abbott (strategic investor), Mayo Clinic, IVP and others, plus athletes including Cristiano Ronaldo and LeBron James.
Advanced Labs blood testing
A panel of 65 biomarkers run by Quest Diagnostics across the United States, clinician-reviewed and synced to the app, priced from $199 for a single test to $599 for four tests a year; opened in September 2025 to a 350,000-person waitlist.
Medical-grade hardware
WHOOP 5.0 and WHOOP MG launched in May 2025, the MG being its first medical-grade device with an FDA-cleared electrocardiogram.
Hiring for 2026
Over 600 new roles worldwide in 2026 to support research and development and international expansion.

Challenges and risks

Large, well-funded competitors
WHOOP competes with Garmin and Apple; at $10.1 billion it is valued at roughly one quarter of Garmin's approximately $40 billion market capitalisation, and the CEO's strategy has been to avoid becoming a smartwatch.
Proving the preventive-medicine bet
Public investors will have to credit the bet that continuous biometric data plus periodic blood testing moves wearables from self-quantification into preventive medicine.
Measurement accuracy
Wrist sensing is harder across skin tones, body types and non-periodic sports; for roughly one in 20 to one in 50 users WHOOP recommends wearing the sensor on the bicep.
Highly selective hiring at scale
Filling over 600 roles while keeping approximately one hire for every 750 applicants, an acceptance rate of .13%.

What leadership says

“Our next step is an IPO”

Will Ahmed, Founder and CEO · Interview with Yahoo Finance quoted by The Next Web after the Series G, 4 April 2026

“We are building the personal health platform that people use to improve their health and livelihood.”

Will Ahmed, Founder and CEO · Series G press release, 31 March 2026

“We are doing both.”

Will Ahmed, Founder and CEO · On hiring versus investing in AI, 2026 hiring press release, 4 March 2026

“All of that information is going to be under one roof.”

Will Ahmed, Founder and CEO · The Rich Roll Podcast, July 2025, on wearable, blood and other health data

Where a supplier can help

Clinical and diagnostics partnerships
The move into a personal health platform (ECG, blood pressure, Advanced Labs) creates needs for lab, clinical-review and medical data partners in each new country.
Market entry in Europe, the GCC, Latin America and Asia
International expansion funded by the Series G calls for localisation, logistics, payments and retail or distribution partners in the new regions.
AI and data infrastructure
Running AI coaching over more than 24 billion hours of physiological data points to suppliers of data platforms, model tooling and privacy and security services.
IPO readiness
The no-regrets work to become a public company opens room for finance systems, reporting, governance, audit and investor-relations providers.
Recruiting and onboarding at scale
The plan to hire over 600 people in 2026, mostly in Boston, fits recruiting, assessment, HR and onboarding tools.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like WHOOP?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about WHOOP

What does WHOOP do?

WHOOP sells a screenless wearable as a membership. It measures strain, recovery and sleep around the clock and adds health features such as an FDA-cleared ECG, Blood Pressure Insights and Advanced Labs blood testing, with AI coaching in its app.

How big is WHOOP?

WHOOP has over 2.5 million members and exited 2025 with a $1.1B bookings run rate after 103% year-over-year growth; it operated cash flow positive in 2025 and was valued at $10.1 billion in March 2026.

Who owns WHOOP?

WHOOP is a private, venture-backed company. Its Series G was led by Collaborative Fund, with investors such as the Qatar Investment Authority, Mubadala, Abbott and Mayo Clinic; the CEO says the next step is an IPO.

Who leads WHOOP?

Will Ahmed founded WHOOP in 2012 as a Harvard student-athlete, with John Capodilupo and Aurelian Nicolae, and is its CEO.

What is WHOOP's strategy?

It aims to become a personal health platform for preventive health, expanding internationally across Europe, the GCC, Latin America and Asia and adding more than 600 roles in 2026.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)